Publications in collaboration with researchers from Universidad de Sevilla (4)

2026

  1. Real-World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA Registry

    Alimentary Pharmacology and Therapeutics, Vol. 64, Núm. 6, pp. 781-791

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Psychiatric polygenic risk as a predictor of COVID-19 risk and severity: insight into the genetic overlap between schizophrenia and COVID-19

    Translational Psychiatry, Vol. 13, Núm. 1

2019

  1. Polymorphisms in CEP68 gene associated with risk of immediate selective reactions to non-steroidal anti-inflammatory drugs

    Pharmacogenomics Journal, Vol. 19, Núm. 2, pp. 191-199